Obesity

Latest News

Amgen Reports Promising Phase 2 Data on MariTide for Obesity, Type 2 Diabetes Management / Image credit: ©MichaelVi/AdobeStock
Amgen Reports Promising Phase 2 Data on MariTide for Obesity, Type 2 Diabetes Management

November 26th 2024

The investigational weight loss drug showed substantial weight loss among people with obesity or overweight with or without T2D without plateaus.

US Trends in Obesity-Related Ischemic Heart Disease Mortality: Daily Dose / image credit: ©New Africa/AdobeStock
US Trends in Obesity-Related Ischemic Heart Disease Mortality: Daily Dose

November 22nd 2024

More than Half of US Adults May Be Eligible for Semaglutide Therapy / image credit Dhruv Kazi, MD, MSc, MS Smith Center for Outcomes Research in Cardiology
More than Half of US Adults May Be Eligible for Semaglutide Therapy, Accordng to New Estimates

November 21st 2024

Metabolic Bariatric Surgery Takes a Backseat as GLP-1RA Use Rises: Daily Dose / image credit: ©New Africa/AdobeStock
Metabolic Bariatric Surgery Takes a Backseat as GLP-1RA Use Rises: Daily Dose

November 20th 2024

GLP-1RAs Cut Early Colorectal Cancer Risk in Adults with T2D: Daily Dose / image credit: ©New Africa/AdobeStock
GLP-1RAs Cut Early Colorectal Cancer Risk in Adults with T2D: Daily Dose

November 14th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.